Placentex (Italian pharmaceutical)
G_PLACENTEXWhat does this word mean?
An Italian PDRN injectable pharmaceutical and an early representative of PDRN's development as a medicine.
Expanded note
PDRN was first isolated from human placenta and entered drug development in Italy, and Placentex represents that lineage. It is widely described as a pharmaceutical, but no official AIFA catalogue entry has been obtained, so its status remains under verification and it is not presented as approved. It is also the textbook case of cross-border use and local cosmetic use being two separate legal questions.
Not a generic example.
The Italian pharmaceutical status of Placentex remains under verification: no official AIFA catalogue entry has been confirmed.
Related terms
Where this term appears
Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.
PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.
PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.